top of page
Search

VNIT's Breakthrough Arteriovenous Implant Unveiled in 2025 Boosts Dialysis Success

VNIT's Breakthrough Arteriovenous Implant Unveiled in 2025 Boosts Dialysis Success
VNIT's Breakthrough Arteriovenous Implant Unveiled in 2025 Boosts Dialysis Success

Researchers at the Visvesvaraya National Institute of Technology in Nagpur have developed a groundbreaking arteriovenous implant that promises to significantly improve dialysis success rates for patients with end-stage renal disease.


The innovative jacket-type device, funded by the Department of Science and Technology with Rs 26 lakh, addresses one of the most persistent challenges in dialysis treatment.


Completed and publicly announced in August 2025, the implant represents the first major advancement in arteriovenous fistula technology to emerge from Vidarbha's premier technical institution.


This medical device innovation could potentially revolutionise vascular access procedures for thousands of kidney failure patients across India who depend on regular dialysis for survival.


Engineering Solution for Critical Medical Challenge


The VNIT team, led by former director Professor P.M. Padole, nephrologist Dr Dhananjay Ookalkar, and experts from mechanical engineering, tackled a longstanding problem in creating arteriovenous fistulae for dialysis patients.


An arteriovenous fistula involves a surgical connection between an artery and vein, typically in the arm, to provide access for haemodialysis treatment.

Despite being considered the gold standard for dialysis access, nearly half of all arteriovenous fistulae fail early due to complications, including vessel blockage and turbulent blood flow.

The research project resulted in a novel jacket-type implant constructed from implant-grade silicone that maintains the ideal 45-degree angle between artery and vein during surgical procedures. This specific angle optimisation ensures smooth blood flow during dialysis sessions while reducing complications that typically lead to fistula failure.


The implant addresses critical hemodynamic factors that influence the success of arteriovenous fistula maturation and long-term functionality.


Abhijeet Raut, the PhD scholar who spearheaded the innovation under the supervision of Professor Padole and Dr Rashmi Uddanwadiker, has received two patents for this work and published three research papers based on the development.


His achievement was recognised with a prize at the National Innovation Competition, highlighting the significance of this medical device advancement. The interdisciplinary collaboration between biomedical engineers and medical specialists exemplifies the type of innovation emerging from technical institutions in central India.


Comprehensive Testing and Validation Process


The implant development followed rigorous testing protocols, beginning with advanced computer simulations before progressing to validation through animal trials.


The research team collaborated with Nagpur Veterinary College to conduct studies on goats, marking the first time such large animal studies with complete ethical approvals have been carried out in central India for this type of medical device.

Regular ultrasound monitoring and pathology studies confirmed reduced inflammation and improved healing compared to conventional surgical methods.


The animal trials demonstrated that the silicone implant successfully maintained the optimal arteriovenous connection angle while promoting better vascular adaptation. Pathology studies revealed enhanced tissue integration and reduced inflammatory response, critical factors for long-term implant success.


The comprehensive testing approach, spanning computational modelling to live animal validation, reflects international standards for medical device development and regulatory approval processes.


This validation methodology represents a significant advancement for medical device research capabilities within the Vidarbha region.


The collaboration between VNIT researchers and Nagpur Veterinary College established important precedents for future biomedical engineering projects requiring animal studies.


The successful completion of these trials with full ethical approvals demonstrates the growing sophistication of research infrastructure in central India's academic institutions.


Technical Innovation and Material Science Breakthrough


The choice of implant-grade silicone for the device construction reflects careful consideration of biocompatibility, durability, and mechanical properties required for vascular applications.


Medical-grade silicones are specifically designed for healthcare applications, offering exceptional purity, flexibility, and resistance to sterilisation processes essential for implantable devices.

The material exhibits biocompatibility meeting international standards while providing the mechanical stability necessary to maintain optimal arteriovenous connection geometry.


Research into arteriovenous fistula hemodynamics indicates that the 45-degree angle represents an optimal configuration for blood flow characteristics.


Computational studies demonstrate that this specific angle provides moderate wall shear stress conditions that promote healthy vein maturation while maximising venous outflow rates essential for effective dialysis treatment.


The VNIT implant's ability to consistently maintain this critical angle addresses a key variable that surgeons traditionally manage through manual technique alone.


The jacket-type design represents an innovative approach to surgical assistance in arteriovenous fistula creation. Unlike traditional surgical methods that rely entirely on the surgeon's skill and experience to achieve optimal connection angles, the implant provides mechanical guidance that standardises this critical aspect of the procedure.


This standardisation could potentially reduce variability in surgical outcomes and improve overall success rates across different skill levels and clinical settings throughout Vidarbha and beyond.


Arteriovenous fistula failure rates in India range from 20 to 60 percent, representing a significant clinical challenge for nephrologists and vascular surgeons treating end-stage renal disease patients.


The VNIT implant addresses primary causes of failure, including inadequate flow development, thrombosis, and stenosis formation that commonly occur at the arteriovenous connection site. By optimising the critical angle between vessels, the device could substantially improve maturation rates and long-term patency of arteriovenous fistulae.


The innovation emerges from the Biomedical Engineering and Technology Incubation Centre at VNIT, part of a broader initiative to develop indigenous medical devices suited to Indian healthcare needs.


This centre, established through collaboration between IIT Bombay, VNIT, and COE Pune, has identified over 450 unmet medical needs and developed multiple innovative solutions. The arteriovenous implant represents one of the most clinically significant outputs from this comprehensive medical device development programme.


Dr Dhananjay Ookalkar, the nephrologist collaborating on this project, brings extensive clinical experience in dialysis access management to the research team.


As managing director of Ashwini Kidney and Dialysis Centre and a contributor to Indian Society of Nephrology guidelines for dialysis, his involvement ensures the device development remains focused on practical clinical applications. His expertise in quality, affordable dialysis provision aligns with the project's goal of improving treatment outcomes for kidney disease patients across economic strata.


The device represents a potential game-changer for surgical procedures, with researchers indicating it could ease surgical complexity while improving the quality of life for kidney patients.


As healthcare infrastructure continues expanding in Vidarbha and broader Maharashtra, innovations like this arteriovenous implant could significantly impact patient outcomes in regional medical centres.

The successful development of this device at VNIT demonstrates the growing capacity of technical institutions in central India to contribute meaningfully to healthcare innovation and medical device manufacturing.


References



 

Comments

Rated 0 out of 5 stars.
No ratings yet
Add a rating

About the Author

The NewsDirt is a trusted source for authentic, ground-level journalism, highlighting the daily struggles, public issues, history, and local stories from Vidarbha’s cities, towns, and villages. Committed to amplifying voices often ignored by mainstream media, we bring you reliable, factual, and impactful reporting from Vidarbha’s grassroots.

bottom of page